Celebrating a breakthrough: the first-ever FDA-approved treatment for geographic atrophy: a correspondence
Int J Surg
.
2023 Aug 1;109(8):2559-2560.
doi: 10.1097/JS9.0000000000000477.
Authors
Abdul Moiz Khan
1
,
Syeda Shahnoor
2
,
Hareem Khan
1
,
Marium Affendi
1
,
Sawsane Ahmad Ghaddar
3
Affiliations
1
Department of Internal Medicine, Ayub Medical College, Abbottabad.
2
Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
3
Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
PMID:
37195786
PMCID:
PMC10442090
DOI:
10.1097/JS9.0000000000000477
No abstract available
MeSH terms
Drug Approval*
Geographic Atrophy* / drug therapy
Humans
United States Food and Drug Administration